{"id":"W1968524867","doi":"10.1053/j.seminoncol.2010.06.001","title":"Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Zoledronic acid; Renal cell carcinoma; Cancer; Placebo; Internal medicine; Oncology; Bladder cancer; Bone disease; Urology; Kidney cancer; Surgery; Pathology; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001904149,0.0005795222,0.002982429,0.0004599712,0.00004102724,0.000009247381,0.0001513877,0.0009397708,0.0006493631],"category_scores_gemma":[0.00008430588,0.0003707609,0.000162495,0.0004517176,0.0001447488,0.00008116708,0.0000928852,0.001516902,0.00006384306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001464922,"about_ca_system_score_gemma":0.003838383,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004570643,"about_ca_topic_score_gemma":0.02776129,"domain_scores_codex":[0.9969832,0.0003230972,0.0009237652,0.0007450266,0.0002810202,0.0007438873],"domain_scores_gemma":[0.99799,0.0004992468,0.0005284341,0.0005934541,0.0000731164,0.0003158098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001382981,0.001865587,0.07635058,0.002110531,0.0001465542,0.002632533,0.0001264617,1.667804e-7,6.006051e-7,7.733716e-7,0.001695368,0.9136879],"study_design_scores_gemma":[0.008815361,0.002919061,0.01452242,0.007661956,0.002060693,0.00007215328,0.00001556415,9.395589e-7,0.00001028468,0.000003526534,0.9635612,0.000356879],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1261308,0.8706413,3.545281e-7,0.00004905737,0.0004361183,0.001940181,0.0005702779,0.00001833885,0.0002135373],"genre_scores_gemma":[0.003294662,0.9910345,0.001569846,0.0003391865,0.0001029981,0.0008014528,0.001516762,0.0001033284,0.001237267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9618658,"threshold_uncertainty_score":0.9998744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04216482054983896,"score_gpt":0.3604882786700274,"score_spread":0.3183234581201885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}